Metformin 1000mg

DRUG2 trials

Sponsors

Boehringer Ingelheim, Dong Wha Pharmaceutical Co. Ltd.

Conditions

Diabetes Mellitus, Type 2Healthy

Phase 1

Pharmacokinetic Profiles of Metformin With DW1029M

CompletedNCT02212756

Dong Wha Pharmaceutical Co. Ltd.Healthy

Start: 2014-08-31End: 2015-02-28Updated: 2015-06-29

Phase 3

Study to Compare the Efficacy and Safety of Administration of the Fix Dose Combination of Linagliptin Plus Metformin in Drug naïve Type 2 Patients

CompletedNCT01708902

Boehringer IngelheimDiabetes Mellitus, Type 2

Start: 2012-10-31End: 2014-04-30Updated: 2015-04-24

Related Papers

Early Combination Therapy with Linagliptin and Metformin in People with Type 2 Diabetes Improves Glycemic Control to HbA1c ≤ 6.5% without Increasing Hypoglycemia: Pooled Analysis of Two Randomized Clinical Trials

Diabetes Therapy2020-04-2310 citations